Next Article in Journal
The Effect of a Product Placement Intervention on Pupil’s Food and Drink Purchases in Two Secondary Schools: An Exploratory Study
Previous Article in Journal
Current Advancements in Antitumor Properties and Mechanisms of Medicinal Components in Edible Mushrooms
 
 
Article

Growth and Gastrointestinal Tolerance in Healthy Term Infants Fed Milk-Based Infant Formula Supplemented with Five Human Milk Oligosaccharides (HMOs): A Randomized Multicenter Trial

Abbott Nutrition, Columbus, OH 43219, USA
*
Author to whom correspondence should be addressed.
Nutrients 2022, 14(13), 2625; https://doi.org/10.3390/nu14132625
Received: 11 May 2022 / Revised: 9 June 2022 / Accepted: 16 June 2022 / Published: 24 June 2022
(This article belongs to the Section Pediatric Nutrition)
Background: Five of the most abundant human milk oligosaccharides (HMOs) in human milk are 2′-fucosyllactose (2′-FL), 3-fucosyllactose (3-FL), lacto-N-tetraose (LNT), 3′-sialyllactose (3′-SL) and 6′-sialyllactose (6′-SL). Methods: A randomized, double-blind, controlled parallel feeding trial evaluated growth in healthy term infants fed a control milk-based formula (CF; n = 129), experimental milk-based formula (EF; n = 130) containing five HMOs (5.75 g/L; 2′-FL, 3-FL, LNT, 3′-SL and 6′-SL) or human milk (HM; n = 104). Results: No significant differences (all p ≥ 0.337, protocol evaluable cohort) were observed among the three groups for weight gain per day from 14 to 119 days (D) of age, irrespective of COVID-19 or combined non-COVID-19 and COVID-19 periods. There were no differences (p ≥ 0.05) among the three groups for gains in weight and length from D14 to D119. Compared to the CF group, the EF group had more stools that were soft, frequent and yellow and were similar to the HM group. Serious and non-serious adverse events were not different among groups, but more CF-fed infants were seen by health care professionals for illness from study entry to D56 (p = 0.044) and D84 (p = 0.028) compared to EF-fed infants. Conclusions: The study demonstrated that the EF containing five HMOs supported normal growth, gastrointestinal (GI) tolerance and safe use in healthy term infants. View Full-Text
Keywords: five human milk oligosaccharides; 2′-FL; 3-FL; LNT; 3′-SL; 6′-SL; infant growth; gastrointestinal tolerance five human milk oligosaccharides; 2′-FL; 3-FL; LNT; 3′-SL; 6′-SL; infant growth; gastrointestinal tolerance
Show Figures

Figure 1

MDPI and ACS Style

Lasekan, J.; Choe, Y.; Dvoretskiy, S.; Devitt, A.; Zhang, S.; Mackey, A.; Wulf, K.; Buck, R.; Steele, C.; Johnson, M.; Baggs, G. Growth and Gastrointestinal Tolerance in Healthy Term Infants Fed Milk-Based Infant Formula Supplemented with Five Human Milk Oligosaccharides (HMOs): A Randomized Multicenter Trial. Nutrients 2022, 14, 2625. https://doi.org/10.3390/nu14132625

AMA Style

Lasekan J, Choe Y, Dvoretskiy S, Devitt A, Zhang S, Mackey A, Wulf K, Buck R, Steele C, Johnson M, Baggs G. Growth and Gastrointestinal Tolerance in Healthy Term Infants Fed Milk-Based Infant Formula Supplemented with Five Human Milk Oligosaccharides (HMOs): A Randomized Multicenter Trial. Nutrients. 2022; 14(13):2625. https://doi.org/10.3390/nu14132625

Chicago/Turabian Style

Lasekan, John, Yong Choe, Svyatoslav Dvoretskiy, Amy Devitt, Sue Zhang, Amy Mackey, Karyn Wulf, Rachael Buck, Christine Steele, Michelle Johnson, and Geraldine Baggs. 2022. "Growth and Gastrointestinal Tolerance in Healthy Term Infants Fed Milk-Based Infant Formula Supplemented with Five Human Milk Oligosaccharides (HMOs): A Randomized Multicenter Trial" Nutrients 14, no. 13: 2625. https://doi.org/10.3390/nu14132625

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop